KeyBank National Association’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
5,825
+126
| +2% | +$24.7K | ﹤0.01% | 581 |
|
|
2026
Q1 | $1.12M | Sell |
5,699
-1,806
| -24% | -$351K | ﹤0.01% | 574 |
|
|
2025
Q4 | $1.3M | Sell |
7,505
-6,745
| -47% | -$1.23M | ﹤0.01% | 525 |
|
|
2025
Q3 | $2.72M | Buy |
14,250
+279
| +2% | +$49.5K | 0.01% | 389 |
|
|
2025
Q2 | $2.51M | Buy |
13,971
+7,054
| +102% | +$1.23M | 0.01% | 395 |
|
|
2025
Q1 | $1.17M | Buy |
6,917
+1,409
| +26% | +$231K | ﹤0.01% | 523 |
|
|
2024
Q4 | $831K | Buy |
5,508
+1,945
| +55% | +$303K | ﹤0.01% | 608 |
|
|
2024
Q3 | $553K | Buy |
3,563
+191
| +6% | +$28.5K | ﹤0.01% | 733 |
|
|
2024
Q2 | $462K | Sell |
3,372
-691
| -17% | -$94.6K | ﹤0.01% | 774 |
|
|
2024
Q1 | $541K | Sell |
4,063
-103
| -2% | -$13.4K | ﹤0.01% | 721 |
|
|
2023
Q4 | $574K | Buy |
4,166
+276
| +7% | +$36.3K | ﹤0.01% | 692 |
|
|
2023
Q3 | $474K | Buy |
3,890
+36
| +0.9% | +$4.8K | ﹤0.01% | 708 |
|
|
2023
Q2 | $542K | Buy |
3,854
+342
| +10% | +$47.1K | ﹤0.01% | 673 |
|
|
2023
Q1 | $497K | Buy |
3,512
+1,084
| +45% | +$155K | ﹤0.01% | 702 |
|
|
2022
Q4 | $380K | Sell |
2,428
-111
| -4% | -$16K | ﹤0.01% | 787 |
|
|
2022
Q3 | $312K | Sell |
2,539
-551
| -18% | -$72.6K | ﹤0.01% | 835 |
|
|
2022
Q2 | $411K | Buy |
3,090
+491
| +19% | +$66.9K | ﹤0.01% | 748 |
|
|
2022
Q1 | $356K | Sell |
2,599
-12
| -0.5% | -$1.67K | ﹤0.01% | 851 |
|
|
2021
Q4 | $452K | Buy |
2,611
+275
| +12% | +$41.8K | ﹤0.01% | 816 |
|
|
2021
Q3 | $339K | Buy |
2,336
+181
| +8% | +$26.5K | ﹤0.01% | 912 |
|
|
2021
Q2 | $284K | Buy |
2,155
+177
| +9% | +$23.2K | ﹤0.01% | 953 |
|
|
2021
Q1 | $254K | Sell |
1,978
-387
| -16% | -$47.7K | ﹤0.01% | 970 |
|
|
2020
Q4 | $282K | Buy |
2,365
+605
| +34% | +$73.8K | ﹤0.01% | 913 |
|
|
2020
Q3 | $202K | Buy |
+1,760
| New | +$208K | ﹤0.01% | 945 |
|
|
2017
Q4 | – | Sell |
-2,588
| Closed | -$242K | – | 1066 |
|
|
2017
Q3 | $242K | Sell |
2,588
-194
| -7% | -$20.6K | ﹤0.01% | 973 |
|
|
2017
Q2 | $309K | Sell |
2,782
-307
| -10% | -$32.5K | ﹤0.01% | 942 |
|
|
2017
Q1 | $303K | Buy |
3,089
+85
| +3% | +$8.1K | ﹤0.01% | 967 |
|
|
2016
Q4 | $276K | Buy |
3,004
+443
| +17% | +$38.2K | ﹤0.01% | 981 |
|
|
2016
Q3 | $217K | Buy |
2,561
+68
| +3% | +$5.71K | ﹤0.01% | 1081 |
|
|
2016
Q2 | $203K | Buy |
+2,493
| New | +$190K | ﹤0.01% | 1044 |
|
|
2015
Q2 | – | Sell |
-2,737
| Closed | -$210K | – | 1221 |
|
|
2015
Q1 | $210K | Sell |
2,737
-346
| -11% | -$24.8K | ﹤0.01% | 1146 |
|
|
2014
Q4 | $207K | Buy |
+3,083
| New | +$195K | ﹤0.01% | 1147 |
|
|
2014
Q3 | – | Sell |
-3,697
| Closed | -$217K | – | 1238 |
|
|
2014
Q2 | $217K | Sell |
3,697
-541
| -13% | -$31.7K | ﹤0.01% | 1183 |
|
|
2014
Q1 | $245K | Sell |
4,238
-351
| -8% | -$18.8K | ﹤0.01% | 1149 |
|
|
2013
Q4 | $246K | Buy |
4,589
+26
| +0.6% | +$1.54K | ﹤0.01% | 1136 |
|
|
2013
Q3 | $282K | Sell |
4,563
-3,454
| -43% | -$207K | ﹤0.01% | 1075 |
|
|
2013
Q2 | $486K | Buy |
+8,017
| New | +$478K | ﹤0.01% | 990 |
|
Other funds holding DGX
EIG
KeyBank National Association's DGX Position: Q2 2026 in Review
KeyBank National Association increased its Quest Diagnostics (DGX) stake by 2.2% in Q2 2026, buying an estimated $24.7K and bringing the position to 5,825 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #581.
KeyBank National Association first reported a position in DGX in Q2 2013 and has held it in 37 quarters since. The position peaked at $2.72M in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- KeyBank National Association held 5,825 shares of Quest Diagnostics worth $1.23M as of Q2 2026.
- KeyBank National Association bought 126 Quest Diagnostics shares in Q2 2026, an estimated $24.7K.
- Quest Diagnostics made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #581 holding.
- KeyBank National Association first reported a position in Quest Diagnostics in Q2 2013 and has held it in 37 quarters since.
- KeyBank National Association's Quest Diagnostics position peaked at $2.72M in Q3 2025.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.